We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Company Streamlines Detecting, Diagnosing, and Tracking Infectious Disease

By LabMedica International staff writers
Posted on 01 Apr 2014
Print article
A company is using its DNA analysis technology in major global collaborations aimed at curbing the spread of viruses such as H1N1 or avian flu, in real time.

The Jerusalem-based subsidiary of Azure PCR (Jerusalem, Israel) has streamlined the process of detecting, diagnosing, and tracking infectious diseases. The company is participating in the largest-ever child health study, the Johns Hopkins (Baltimore, MD, USA)-based PERCH (Pneumonia Etiology Research for Child Health. This multicountry study of hospitalized pediatric patients with severe pneumonia aims to advance new lab techniques in order to better determine causes and risk factors, as well as guide the development of new vaccines and treatments.

The Israeli company’s role in this USD 260 million study is its unique capability for fast and automated data analysis. At this early stage, however, the company is not focusing on consumer application but on using its automatic DNA analysis technology in major global collaborations aimed at curbing the spread of viruses such as H1N1 or avian flu, in real time.

There are three steps to the process: extracting the DNA from a urine or blood sample, testing the DNA, and analyzing the results. The first two steps were automated before Azure PCR came on the scene. Real-time polymerase chain reaction (PCR) is the most popular molecular diagnostic technique in use today, accounting for more than USD 2.8 billion in sales. The breakthrough is automating the analysis step—greatly speeding up the process, removing the need for specially trained technicians (a particularly acute issue for developing countries where skilled professionals can be hard to find), and eliminating room for error in interpreting results.

CEO of Azure PCR, Aron Cohen said, “We make the subjective objective. We can provide standardized results without the need for skilled personnel. With major global pandemics such as SARS and swine flu, we saw a 6- to 18-month lag in diseases that start[ed] in developing nations until spreading to the West, so being able to track these in real time can make prevention through vaccination and other methods possible,” Cohen explained.

“Putting early warning systems in place can improve people’s lives and cut down on the cost of universal healthcare. If we know there is a disease spreading from a town and can map its distribution patterns, targeted vaccination can prevent it from spreading. Prevention is always better than cure.”

Related Links:

Azurepcr
Johns Hopkins 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.